Breath Therapeutics
Germany
acquiredacquired
acquired
Stage
2017
Founded
About
Breath Therapeutics is a biopharmaceutical company developing drug-aerosol therapeutics for rare pulmonary diseases, focusing on a proprietary nebulized cyclosporine A treatment for Bronchiolitis Obliterans Syndrome in lung transplant patients.
Explore Breath Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.